Pembrolizumab plus chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
Authors
Chung, HCBang, YJ
Tabernero, J
Van Cutsem, E
Fuchs, CS
Wyrwicz, L
Lee, KW
Kudaba, I
Garrido, M
Castro, H
Mansoor, Was
Braghiroli, MI
Goekkurt, E
Chao, J
Wainberg, ZA
Kher, U
Shah, S
Shitara, K
Affiliation
Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of KoreaIssue Date
2019
Metadata
Show full item recordCitation
Chung HC, Bang YJ, Tabernero J, Van Cutsem E, Fuchs CS, Wyrwicz L, et al. Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study. Annals of Oncology. 2019;30:ix43-ix4.Journal
Annals of OncologyDOI
10.1093/annonc/mdz422.003Additional Links
https://dx.doi.org/10.1093/annonc/mdz422.003Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdz422.003